The Food and Drug Administration (FDA) should cease and desist from any additional statements regarding suicide related to this product. This product significantly enhances life instead of causing any negative thoughts or feelings. Reports to the contrary are outrageous. Televised reports from news services have stated that there have been 3 suicides out of 31 million Singulair users. The FDA is just as well to review the link between lightning strikes to asthma inhalers causing suicide. We have to state again that to have this pubicized in such a manner is not only unconscionable but also poses a serious risk to the public. AAEA appeals to news services to stop publicizing this fiction immediately.
It is being reported that the FDA is reviewing a handful of reports, not clinical studies, involving mood changes, suicidal behavior and suicide in patients who have taken Singulair. Singulair is used by millions of patients in the U.S. and was first approved in 1998. How the FDA could or would allow these reports to become public without any clinical studies, which are the standard tool for evaluating drug safety, is mind boggling. Published reports indicate that there were no suicides in the 11,000 patients enrolled in 40 Singulair trials. Now Merck will have to spend millions of dollars in advertising to reverse false impressions instead of lowering the price for those who need the medication but do not have health insurance. (The Washington Post)